Health ❯ Healthcare ❯ Obesity

Weight Loss Treatments

GLP-1 Medications GLP-1 Agonists GLP-1 Receptor Agonists Semaglutide GLP-1 Drugs Tirzepatide Side Effects Injections Mounjaro Orforglipron Endoscopic Sleeve Gastroplasty Semaglutide for Weight Loss Investigational Drugs Ozempic Zepbound Bariatric Surgery Mounjaro vs Wegovy GLP-1 Therapy NHS Initiatives Clinical Trials Medications Pills Pharmaceuticals NHS Funding Cancer Prevention NHS and Private Clinics Pill Form Medications Oral Medications GLP1 Drugs RNA Modifications RES-010 Medication Efficacy Risks and Benefits CagriSema GLP-1 Injections Risks of Unsupervised Use Weight Loss Injections Wegovy Hormone Agonists GLP-1 Therapies Eli Lilly Foundayo Oral Semaglutide Weight Loss Pens GLP-1 Oral Medications

AstraZeneca’s Oral GLP‑1 Elecoglipron Delivers Strong Phase 2 Weight and Blood‑Sugar Results

The company has launched a Phase 3 program to evaluate long‑term safety, refine dosing and run dedicated cardiovascular and kidney outcome trials.

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss